| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $186.8M | -0.8% |
| R&D Expense | $67.6M | +5.5% |
| SG&A Expense | $75.5M | -9.4% |
| Operating Income | -$30.1M | +11.8% |
| Interest Expense | $8.4M | +43.8% |
| Pre-tax Income | -$37.3M | +11.8% |
| Income Tax | $325K | -33.4% |
| Net Income | -$37.5M | +12.4% |
| EPS (Basic) | -$0.21 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.6M | -67.3% |
| Accounts Receivable | $35.5M | +3.1% |
| Inventory | $39.9M | +37.5% |
| Current Assets | $144.4M | -15.1% |
| Total Assets | $197.7M | -9.3% |
| Current Liabilities | $67.5M | -42.3% |
| Total Liabilities | $144.3M | -3.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$43.2M | -68.5% |
| Capital Expenditures | $4.6M | +129.8% |
| Investing Cash Flow | $8.6M | +1.9% |
| Financing Cash Flow | $10.7M | +154.6% |
| Free Cash Flow | -$47.8M | -73.0% |
| +12.5% |
| EPS (Diluted) | -$0.21 | +12.5% |
| Stockholders' Equity |
| $52.6M |
| -22.1% |